The Pharmaceutical Research and Manufacturers of America and the European Federation of Pharmaceutical Industries and Associations said the sharing of clinical trial data will improve public health and advance the care of patients as well as boost research and scientific knowledge. "Imperative to the success of this initiative are safeguards that ensure patient privacy, respect for integrity of regulatory systems worldwide and greater incentives for more investment in medical innovation," PhRMA Chairman and Celgene CEO Bob Hugin said.

Related Summaries